The risk of cardiovascular morbidity and mortality is highly increased in patients with diabetic nephropathy. Postulating that the generalized vasculopathy observed in these patients may enhance transcapillary filtration of lipids and lipoproteins resulting in a more atherogenic interstitial lipid profile, we set out to analyze the composition of their interstitial fluid. We studied healthy control subjects (n = 9), normoalbuminuric insulin-dependent diabetes mellitus (IDDM) patients (n = 16), and IDDM patients with diabetic nephropathy (n = 11) matched for age, body mass index, smoking habits, duration of diabetes, and metabolic control. Interstitial fluid was collected after an overnight fast by applying mild suction (200 mmHg) to the skin. Interstitial apolipoprotein A-I (apoA-I) levels were significantly lower in patients with nephropathy (0.18 ± 0.10 g/l [mean ± SD]) compared with normoalbuminuric diabetic patients (0.29 ± 0.08 g/l) and healthy control subjects (0.30 ± 0.09 g/l). Interstitial apolipoprotein B:apoA-I ratios tended to be higher in patients with diabetic nephropathy. In these patients, normal interstitial low-density lipoprotein cholesterol concentrations were observed in the presence of lower apoA-I levels. Transcapillary filtration of apoA-I was significantly lower in patients with diabetic nephropathy. Furthermore, an altered multiple regression model explaining interstitial apoA-I levels was observed in diabetic nephropathy. In this model, transcapillary protein (IgG) filtration and serum apoA-I levels no longer explained interstitial apoA-I levels. If we assume that interstitial apoA-I is involved in reverse cholesterol transport, these data suggest a more atherogenic interstitial lipoprotein profile in IDDM patients with nephropathy.
Skip Nav Destination
Article navigation
Original Articles|
May 01 1995
Decreased Interstitial Apolipoprotein A-I Levels in IDDM Patients with Diabetic Nephropathy
Jouke T Tamsma;
Jouke T Tamsma
Department of Endocrinology, PG-TNO
Leiden, The Netherlands
Search for other works by this author on:
Frederique H Beverdam;
Frederique H Beverdam
Department of Endocrinology, PG-TNO
Leiden, The Netherlands
Search for other works by this author on:
Jan A. Gevers Leuven;
Jan A. Gevers Leuven
University Hospital and Gaubius Laboratory, PG-TNO
Leiden, The Netherlands
Search for other works by this author on:
Herman H P J Lemkes
Herman H P J Lemkes
Department of Endocrinology, PG-TNO
Leiden, The Netherlands
Search for other works by this author on:
Address correspondence and reprint requests to Dr. J.T. Tamsma, Department of Endocrinology, University Hospital, Building 1, C4-R, PO Box 9600, 2300 RC Leiden, The Netherlands.
Diabetes 1995;44(5):501–505
Article history
Received:
September 29 1994
Revision Received:
January 04 1995
Accepted:
January 04 1995
PubMed:
7729606
Citation
Jouke T Tamsma, Frederique H Beverdam, Jan A. Gevers Leuven, Herman H P J Lemkes; Decreased Interstitial Apolipoprotein A-I Levels in IDDM Patients with Diabetic Nephropathy. Diabetes 1 May 1995; 44 (5): 501–505. https://doi.org/10.2337/diab.44.5.501
Download citation file:
25
Views